Not all clients with CLL call for therapy. Despite all modern innovations, the iwCLL however suggests watchful observation for people with asymptomatic illness.86 This recommendation relies on at the least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 The two trials concluded that https://englandy210rjy9.wikiadvocate.com/user